Medical Devices Symposium 2026: Is Everything About Risk Management?
The EU MDR has embedded risk management more deeply into the European regulatory framework than many companies realize. Classification, technical documentation, Post-Market Surveillance (PMS), PMCF, user information, and quality controls now follow a consistent risk logic. This is precisely where the 4th Medical Devices Symposium on April 21, 2026, in Stuttgart comes in: a concise, expert-driven day that positions risk management as a strategic tool – and as the foundation for safe, high-performing medical devices.
Following the 3rd symposium focused on clinical evaluation, the series “Pillars of Technical Documentation” continues and asks: Is everything in the medical device industry really a matter of risk? The answer emerges from combining legal fundamentals, assessment methods, and practical examples – including the integration of risk management, PMS, and clinical evaluation, manufacturer insights, and digital tools.
Program Structure & Benefits for Participants
The day begins with a regulatory overview of the significance of the risk-based approach under the MDR. It then moves into concrete risk analyses across the product lifecycle – including test plans, decision-making frameworks, and the interplay between PMS, clinical evaluation, and risk management. The event concludes with a discussion on digitalization in risk management and a hands-on workshop. Professionals from Regulatory Affairs, Quality Management, R&D, Production, Product Management, and Clinical Evaluation will find a working forum that brings together methods, evidence requirements, and QMS integration.
Three Key Takeaways
- Strengthen regulatory confidence: The MDR links risk-benefit assessment with approval processes, PMS, sampling, and user information – robust risk management accelerates decisions and reduces audit workload.
- Ensure consistent evidence: Clinical evaluation, PMS, and risk management must be seamlessly integrated – the symposium shows how to build robust evidence systems throughout the entire product lifecycle.
- Modernize testing strategies: Using ISO 14971-based risk analyses and digital systems, you’ll learn how to efficiently integrate and track process and product risks within QMS workflows.
Format & Networking
Presentations combine theory, practice, and discussion. Scheduled breaks encourage personal exchange and practical deep dives. This creates a dynamic dialogue between regulatory requirements, methodology, and industry practice, enabling participants to directly apply insights to technical documentation and PMS workflows.
Outlook: Digitalization of Risk Management
The event addresses the future of risk management in the digital era: Which tools support risk identification? Where are the limits of automation? And how can clinical evaluation remain robust and compliant? These guiding questions build on strategies and lessons learned from 2025 and advance toward data-driven decision-making processes.
Who Should Attend?
The symposium is aimed at experts in Regulatory Affairs, Quality Management, Clinical Affairs, Product Development, Production, as well as PMS and risk management professionals. It provides practical insights for implementing MDR-compliant technical documentation while improving efficiency in development and post-market processes.
Date & Venue
The 4th Medical Devices Symposium will take place on April 21, 2026, in Stuttgart. Early bird discounts are available.
Get further information here (in German)